CFO transition
Carlsmed, Inc. CFO transition: Richard Heppenstall to succeed Leo Greenstein
Carlsmed, Inc. reported in a Form 8-K filed September 30, 2026 that Richard Heppenstall will succeed Leo Greenstein as Chief Financial Officer, effective September 28, 2026.
In the filing's words
On September 24, 2026, the Board of Directors of the Company appointed Richard Heppenstall as Chief Financial Officer of the Company, effective September 28, 2026 (the “Transition Date”).
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | Carlsmed, Inc. (CARL) |
|---|---|
| Event | Transition |
| Incoming | Richard Heppenstall |
| Outgoing | Leo Greenstein |
| Title in the filing | Chief Financial Officer |
| Effective | September 28, 2026 |
| 8-K filed | September 30, 2026 |
| Internal promotion | No |
| Prior role (per filing) | Executive Vice President, Chief Financial Officer and Treasurer, ZimVie Inc. |
| SEC CIK | 0001794546 |
Carlsmed, Inc. reported this change in a Form 8-K, Item 5.02, filed September 30, 2026. The filing's own words are quoted above.
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-30
Something wrong about Richard Heppenstall? Send a correction with the primary source.